Tsumura & Co. (TYO:4540)

Market Cap	284.02B -13.3%
Revenue (ttm)	192.62B +6.4%
Net Income	28.12B -13.3%
EPS	376.28 -11.9%
Shares Out	74.54M
PE Ratio	10.13
Forward PE	10.30
Dividend	152.00 (3.99%)
Ex-Dividend Date	Mar 30, 2026

Volume	390,700
Open	3,798.00
Previous Close	3,750.00
Day's Range	3,784.00 - 3,857.00
52-Week Range	3,306.00 - 4,403.00
Beta	0.05
Analysts	Hold
Price Target	4,425.00 (+16.14%)
Earnings Date	May 13, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 4,272
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4540

Financial Performance

In fiscal year 2026, Tsumura & Co.'s revenue was 192.62 billion, an increase of 6.36% compared to the previous year's 181.09 billion. Earnings were 28.12 billion, a decrease of -13.29%.